Oxidative Medicine and Cellular Longevity / 2019 / Article / Tab 5

Research Article

Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway

Table 5

Effects of myricetin on echocardiographic parameters after Nrf2 knockdown.

ScramScram+MyrshRNA+ABshRNA+AB+Myr

10101010
HR (bpm)
IVSd (mm)#
LVEDd (mm)#
LVEPWd (mm)#
IVDs (mm)
LVEDs (mm)#
LVEPWs (mm)#
EF (%)#
FS (%)#

HR: heart rate; IVSd: interventricular septal thickness (IVS) at diastole; IVSs: IVS at systole; LVEDd: LV end-diastolic diameter; LVEDs: LV end-systolic diameter; LVPWd: LV end-diastolic posterior wall thickness; LVPWs: LV end-systolic posterior wall thickness; LVEF: LV ejection fraction; FS: fractional shortening. versus the scram group or the scram+Myr group, # versus the shRNA+AB group.